Virginia researchers claimed to have created artificial pancreas clinical trials to test an individually-”prescribed” control algorithm, which regulates blood glucose levels in Type 1 diabetics. The computerized, subcutaneous system could one day transform the way Type 1 diabetics manage their disease.
Boris Kovatchev, Ph.D., associate professor of psychiatry and neurobehavioral sciences & systems and information engineering who is leading UVA’s research team. Since late June, researchers have successfully tested the new system on five patients at the UVA Health System. An additional three patients have participated in a parallel study at the University of Padova, Italy.
Kovatchev, internationally known for his expertise in applying advanced computational methods to diabetes research, was one of the scientists who developed the system’s novel algorithm, which allows for personalized treatment for each patient. By linking patients’ glucose monitors with their insulin pumps, the “smart” program automatically regulates the amount of insulin a patient needs. Complete results from the initial clinical trials at the UVA Health System, the University of Padova and the University of Montpellier, France are expected by the end of 2008. Kovatchev said,
“This artificial pancreas could one day greatly improve the current methods of self treatment for Type 1 diabetes.Instead of a patient having to measure his or her blood sugar with a glucose meter several times a day and self-administer insulin injections, this system would continuously regulate the patient’s blood glucose, much like the way a non-diabetic’s pancreas functions.”
University of Virginia Health System
PO Box 800795
Source: Medical News Today